Research record
Chronic myeloid leukemia / BCR-ABL source map
CML needs its own pathway because BCR-ABL/Philadelphia chromosome language, disease phase, response monitoring, and TKI discussions are central.
What this is
CML needs its own pathway because BCR-ABL/Philadelphia chromosome language, disease phase, response monitoring, and TKI discussions are central.
Why it may come up
- chronic phase
- accelerated phase
- blast phase
- TKI discussion
- trial search
What not to assume
- Do not provide dose, switching, or resistance-management guidance.
At a glance
Chronic myeloid leukemia / BCR-ABL source map
- Type
- diagnostic-context
- Mutation result
- BCR-ABL / Philadelphia chromosome context
- Where
- Global
- Evidence status
- Source gives context
- Last checked
- 2026-05-21
What we know
- NCI has a dedicated CML Treatment PDQ patient summary.
What is unclear
- TKI-by-country access and response-monitoring explainers are not built yet.
Questions to ask
- Does the report document BCR-ABL or Philadelphia chromosome positivity?
- Which phase is documented: chronic, accelerated, or blast phase?
- What monitoring terms should the family understand before the next visit?